Brief: Meridian Bioscience Inc Reports Q3 Net Loss Per Basic Common Share Of $0.17
05/08/2022 13:22
Aug 5 (Reuters) - Meridian Bioscience Inc VIVO.O :
* MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022
OPERATING
RESULTS
* Q3 REVENUE ROSE 7 PERCENT TO $67.8 MILLION
* AT JUNE 30, 2022, CASH AND CASH EQUIVALENTS WERE $83.5
MILLION
* QTRLY NET LOSS PER BASIC COMMON SHARE $0.17
Source text for Eikon: ID:nPn980wBXa
Further company coverage: VIVO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on VivoPower
See all newsBrief: Vivopower Signs Definitive Heads Of Agreement With Open Innovation Ai To Develop Secure Sovereign Ai Data Centers Across The Nordics, Mainland Europe, The GCC And Selective Countries In Asia
Brief: Vivopower Approves Independent Listing Of 2.2Gw Non-Nordic Ai Infrastructure Platform, Transferring Capital Expenditure Requirements Whilst Retaining De Facto Control
Brief: Vivopower Secures Us$50 Million Pipe At Us$7.50 Conversion Price Per Share
Brief: Vivopower Shortlists Ai Tenants For 41.5Mw Norway Ai Data Center After Receiving Multiple Bids
Brief: Vivopower PLC Prequalifies 30 MW From Mo I Rana Data Center Into Statnett Reserve Markets